Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK

Br J Anaesth. 2024 May;132(5):1004-1006. doi: 10.1016/j.bja.2024.01.047. Epub 2024 Mar 22.
No abstract available

Keywords: CAR-T therapy; ICU; ICU outcomes; haemato-oncology; immune therapies; immunocompromised patients.

Publication types

  • Letter

MeSH terms

  • Cell- and Tissue-Based Therapy
  • Humans
  • Immunotherapy, Adoptive
  • Patients
  • Receptors, Chimeric Antigen*
  • United Kingdom

Substances

  • Receptors, Chimeric Antigen